Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E J Schaefer

Showing results (21-30 of 338) with videos related to

Pageof 34
Sort By:
Preventive Cardiology|February 9, 2002
Perspectives: Benefits of reducing low-density lipoprotein cholesterol concentrations to <100 mg/dLE J Schaefer, M E Brousseau
Clinical Chemistry|February 1, 1987
Sample lipolysis for quantification of apolipoprotein BJ S Cohn, E J Schaefer
The New England Journal of Medicine|May 12, 1988
Dietary saturated fatty acids and blood cholesterolI H Rosenberg, E J Schaefer
The British Journal of Nutrition|July 13, 2000
Genetic determinants of plasma lipid response to dietary intervention: the role of the APOA1/C3/A4 gene cluster and the APOE geneJ M Ordovas, E J Schaefer
Current Atherosclerosis Reports|August 7, 2001
New developments in the prevention of atherosclerosis in patients with low high-density lipoprotein cholesterolM E Brousseau, E J Schaefer
Journal of Lipid Research|August 1, 1978
Lipoprotein apoprotein metabolismE J Schaefer, S Eisenberg, R I Levy
The American Journal of Gastroenterology|December 1, 1976
Treatment of protein-losing gastropathy with atropineM N Gordon, E J Schaefer, M Finkel
Biochemical and Biophysical Research Communications|August 14, 1980
Activation of human post heparin lipoprotein lipase by apolipoprotein H (beta 2-glycoprotein I)Y Nakaya, E J Schaefer, H B Brewer
Biochimica Et Biophysica Acta|July 18, 1986
Impaired hepatocyte binding, uptake and degradation of glucosylated low-density lipoproteinsJ E Triau, J Arbetter, E J Schaefer
Current Opinion in Cardiology|April 7, 1999
Lipoprotein(a), homocysteine, and remnantlike particles: emerging risk factorsL J Seman, J R McNamara, E J Schaefer
Pageof 34

Showing results (21-30 of 338) with videos related to

Sort By:
Pageof 34
Preventive Cardiology|February 9, 2002
Perspectives: Benefits of reducing low-density lipoprotein cholesterol concentrations to <100 mg/dLE J Schaefer, M E Brousseau
Clinical Chemistry|February 1, 1987
Sample lipolysis for quantification of apolipoprotein BJ S Cohn, E J Schaefer
The New England Journal of Medicine|May 12, 1988
Dietary saturated fatty acids and blood cholesterolI H Rosenberg, E J Schaefer
The British Journal of Nutrition|July 13, 2000
Genetic determinants of plasma lipid response to dietary intervention: the role of the APOA1/C3/A4 gene cluster and the APOE geneJ M Ordovas, E J Schaefer
Current Atherosclerosis Reports|August 7, 2001
New developments in the prevention of atherosclerosis in patients with low high-density lipoprotein cholesterolM E Brousseau, E J Schaefer
Journal of Lipid Research|August 1, 1978
Lipoprotein apoprotein metabolismE J Schaefer, S Eisenberg, R I Levy
The American Journal of Gastroenterology|December 1, 1976
Treatment of protein-losing gastropathy with atropineM N Gordon, E J Schaefer, M Finkel
Biochemical and Biophysical Research Communications|August 14, 1980
Activation of human post heparin lipoprotein lipase by apolipoprotein H (beta 2-glycoprotein I)Y Nakaya, E J Schaefer, H B Brewer
Biochimica Et Biophysica Acta|July 18, 1986
Impaired hepatocyte binding, uptake and degradation of glucosylated low-density lipoproteinsJ E Triau, J Arbetter, E J Schaefer
Current Opinion in Cardiology|April 7, 1999
Lipoprotein(a), homocysteine, and remnantlike particles: emerging risk factorsL J Seman, J R McNamara, E J Schaefer
Pageof 34